Radiation boost for melanoma cell therapy shows mixed results

NCT ID NCT01319565

First seen Jan 05, 2026 · Last updated Apr 25, 2026 · Updated 16 times

Summary

This study tested whether adding total body irradiation (TBI) to standard chemotherapy before giving patients their own lab-grown immune cells could improve outcomes for metastatic melanoma. 102 adults with advanced skin cancer were randomly assigned to receive either chemotherapy alone or chemotherapy plus low-dose radiation before the cell infusion. The goal was to see which approach led to better tumor shrinkage and longer survival. While the treatment showed promise, patients needed long-term antibiotics and monitoring, and the approach is not a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.